companydata.dkGemCap Biotech ApS: Financial statements 2022
CVR: 38189174
GemCap Biotech ApS (CVR 38189174) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 27,000. The solvency ratio was 100%.
- Profit/Loss
- 0 kr.
- Equity
- 27,000 kr.
- Total Assets
- 27,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | 0 | 27 t. | - |
| 2021 | - | - | 0 | 7 t. | - |
| 2020 | - | - | 0 | 7 t. | - |
| 2019 | - | - | 0 | 7 t. | - |
| 2018 | - | - | 0 | 7 t. | - |
Keep an eye on GemCap Biotech ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
GemCap Biotech ApS has published its annual report for 2021. The net result was DKK 0.
About GemCap Biotech ApS
GemCap Biotech ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2016 and dissolved in 2024. The company was registered under the industry Anden finansiel formidling undtagen forsikring og pensionsforsikring, i.a.n.. In 2023, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK 27,000.